Successful transition to encorafenib following vemurafenib-induced drug rash with eosinophilia and systemic symptoms syndrome

Detalles Bibliográficos
Autores principales: Young, Peter A., Keller, Lia C., Bae, Gordon H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895670/
https://www.ncbi.nlm.nih.gov/pubmed/33644278
http://dx.doi.org/10.1016/j.jdcr.2020.12.030
_version_ 1783653406708072448
author Young, Peter A.
Keller, Lia C.
Bae, Gordon H.
author_facet Young, Peter A.
Keller, Lia C.
Bae, Gordon H.
author_sort Young, Peter A.
collection PubMed
description
format Online
Article
Text
id pubmed-7895670
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78956702021-02-25 Successful transition to encorafenib following vemurafenib-induced drug rash with eosinophilia and systemic symptoms syndrome Young, Peter A. Keller, Lia C. Bae, Gordon H. JAAD Case Rep Case Report Elsevier 2021-01-11 /pmc/articles/PMC7895670/ /pubmed/33644278 http://dx.doi.org/10.1016/j.jdcr.2020.12.030 Text en © 2021 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Young, Peter A.
Keller, Lia C.
Bae, Gordon H.
Successful transition to encorafenib following vemurafenib-induced drug rash with eosinophilia and systemic symptoms syndrome
title Successful transition to encorafenib following vemurafenib-induced drug rash with eosinophilia and systemic symptoms syndrome
title_full Successful transition to encorafenib following vemurafenib-induced drug rash with eosinophilia and systemic symptoms syndrome
title_fullStr Successful transition to encorafenib following vemurafenib-induced drug rash with eosinophilia and systemic symptoms syndrome
title_full_unstemmed Successful transition to encorafenib following vemurafenib-induced drug rash with eosinophilia and systemic symptoms syndrome
title_short Successful transition to encorafenib following vemurafenib-induced drug rash with eosinophilia and systemic symptoms syndrome
title_sort successful transition to encorafenib following vemurafenib-induced drug rash with eosinophilia and systemic symptoms syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895670/
https://www.ncbi.nlm.nih.gov/pubmed/33644278
http://dx.doi.org/10.1016/j.jdcr.2020.12.030
work_keys_str_mv AT youngpetera successfultransitiontoencorafenibfollowingvemurafenibinduceddrugrashwitheosinophiliaandsystemicsymptomssyndrome
AT kellerliac successfultransitiontoencorafenibfollowingvemurafenibinduceddrugrashwitheosinophiliaandsystemicsymptomssyndrome
AT baegordonh successfultransitiontoencorafenibfollowingvemurafenibinduceddrugrashwitheosinophiliaandsystemicsymptomssyndrome

Ejemplares similares